Limitations
Difficult to collect large cohorts of patients for discovery and replication
Can be difficult to parse effects of environment from genetic effects
Ethical issues with studying drugs with narrow therapeutic indices
Not all cohorts will have detailed pharmacological data, especially retrospective cohorts
|
Phenotype may not recapitulate in vivo system
Subject to in vitro confounders that may affect phenotype
Cell lines can be generated from only a limited number of tissues
Cells may not express important metabolic enzymes relevant to pharmacology, such as the cytochrome P450 family
Establishing cell lines from tumor may alter characteristics of tumor
|